The gene regulation indicators from subterranean clover stunt virus (SCSV) had been investigated for his or her expression in dicot vegetation. The SCSV genome has at the very least eight round DNA molecules. Every round DNA part accommodates a promoter aspect, a single open studying body and a terminator. The promoters from seven of the segments had been examined for his or her energy and tissue specificity in transgenic tobacco (Nicotiana tabacum L.), potato (Solanum tuberosum L.) and cotton (Gossypium hirsutum L.) utilizing a GUS reporter gene assay system.
Whereas the promoters of lots of the segments had been poorly expressed, promoters derived from segments four and seven had been proven to direct excessive ranges of expression in varied plant tissues and organs. The section 1 promoter directs predominantly callus-specific expression and, when used to manage a selectable marker gene, facilitated the transformation of all three species (tobacco, potato and cotton). From the outcomes, a set of plant expression vectors (pPLEX) derived from the SCSV genome had been constructed and used right here to provide herbicide- and insect-resistant cotton, demonstrating their utility within the expression of overseas genes in dicot crop species and their potential to be used in agricultural biotechnology.
Establishing Standardized Biomedical Laboratory Technician Schooling for the Growth of Biotechnology Analysis in China
Chinese language scientists have been actively engaged in biotechnology analysis for the reason that mid-20th century. Nevertheless, biotechnology training, particularly biomedical laboratory know-how training, is comparatively scarce in China. An increasing number of cutting-edge gear and strategies have been launched into biomedical laboratories in China, however there’s a lack of high-quality technicians to use these developments to scientific analysis. As well as, the normal training and apprenticeship programs have been demonstrated little progress. To deal with this hole, West China Hospital of Sichuan College established a 2-year instructional program for laboratory know-how in 2006 primarily based on the residency coaching program.
The challenge integrates scientific strategies into the analysis laboratory technician coaching in related disciplines, and has developed a scientific, scientific, and efficient standardized coaching system to domesticate high-level and secure experimental technician workforce for the necessity of superior laboratories, which has been demonstrated drastically enhance the effectivity of biomedical researchers and laboratory services. On this article, we introduce the sensible expertise in institution and improvement of a standardized coaching system for biomedical laboratory technicians to make sure the sustainable improvement of medical researches.

Holistic Extractables and Leachables Program: Evaluations of Prefilled Syringe Methods for Biotechnology Merchandise
Glass prefilled syringes (PFS) are a container and supply machine of alternative for storing and administering therapeutic protein merchandise to sufferers. Addressing issues and regulatory expectations associated to the danger to biologic drug product high quality and affected person security from PFS requires implementation of an extractable and leachable program primarily based on understanding of supplies, threat evaluation, evaluate of present literature and testing primarily based on a sound scientific basis.
Extractables and leachables information generated as a part of thorough and holistic program are offered for five PFS programs, together with glass and plastic syringes, and 12 biologic drug merchandise encompassing the implementation of conventional and single-use biotechnology manufacturing processes. The great extractables and leachables information offered display and substantiate a holistic extractable and leachable program designed to make sure product high quality and affected person security.
Replace on glioma biotechnology
Neuro-oncological analysis is on the forefront of the rising most cancers remedy market, as evidenced by its rising income and the multitude of scientific trials investigating revolutionary therapy approaches. The Feinstein Institute for Medical Analysis, together with the Division of Neurosurgery at Lenox Hill Hospital and the Zucker College of Drugs at Hofstra / Northwell, sponsored The Mind Tumor Biotech Summit in New York Metropolis in June 2019.
The goal of the Summit was to supply a discussion board that encourages collaboration between most cancers specialists, biotechnology and pharmaceutical business leaders, and the funding neighborhood so as to promote innovation and advance rising therapies for mind tumors. Areas highlighted throughout the Summit included immunotherapy, precision medication, and novel functions and experimental remedies resembling receptor concentrating on, strategies for improved drug supply, and revolutionary intraoperative strategies and applied sciences. This evaluate synthesizes the current breakthroughs in mind tumor analysis as offered at The Mind Tumor Biotech Summit.
Catalytically-active inclusion our bodies for biotechnology-general ideas, optimization, and utility
Bacterial inclusion our bodies (IBs) have lengthy been thought of as inactive, unfolded waste materials produced by heterologous overexpression of recombinant genes. In industrial functions, they’re sometimes used as a substitute in circumstances the place a protein can’t be expressed in soluble kind and in excessive sufficient quantities. Then, nevertheless, refolding approaches are wanted to rework inactive IBs into energetic soluble protein. Whereas anecdotal reviews about IBs themselves displaying catalytic performance/exercise (CatIB) are discovered all through literature, solely not too long ago, the usage of protein engineering strategies has facilitated the on-demand manufacturing of CatIBs.
CatIB formation is induced often by fusing brief peptide tags or aggregation-inducing protein domains to a goal protein. The ensuing proteinaceous particles fashioned by heterologous expression of the respective genes may be thought to be a biologically produced bionanomaterial or, if enzymes are used as goal protein, carrier-free enzyme immobilizates. Within the current contribution, we evaluate common ideas essential for CatIB manufacturing, processing, and utility.
Human Eotaxin 1 (Eotaxin 1/CCL11)ELISA Kit |
|
GA-E0032HM-48Tests |
GenAsia Biotech |
48 Tests |
Ask for price |
Human Eotaxin 1 (Eotaxin 1/CCL11)ELISA Kit |
|
GA-E0032HM-96T |
GenAsia Biotech |
96T |
EUR 559.2 |
Human Eotaxin 1 (Eotaxin 1/CCL11)ELISA Kit |
|
GA-E0032HM-96Tests |
GenAsia Biotech |
96 Tests |
EUR 388 |
Human Eotaxin-1 Antibody |
|
34032-05111 |
AssayPro |
150 µg |
Ask for price |
Mouse Anti Human Eotaxin-2 |
|
MBS140028-05mg |
MyBiosource |
0.5mg |
EUR 440 |
Mouse Anti Human Eotaxin-2 |
|
MBS140028-1mg |
MyBiosource |
1mg |
EUR 600 |
Mouse Anti Human Eotaxin-2 |
|
MBS140028-5x1mg |
MyBiosource |
5x1mg |
EUR 2375 |
GOAT ANTI HUMAN EOTAXIN 2 |
|
MBS221335-01mg |
MyBiosource |
0.1mg |
EUR 545 |
GOAT ANTI HUMAN EOTAXIN 2 |
|
MBS221335-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2275 |
Human Eotaxin-1 (CCL11 ) |
|
90127-A |
BPS Bioscience |
5 µg |
EUR 130 |
|
Description: Recombinant Eotaxin-1 is a disulfide-linked homodimeric protein consisting of 75 amino acid residues, and migrates as an approximately 9 kDa protein under non-reducing and reducing conditions in SDS-PAGE. Optimized DNA sequence encoding human Eotaxin-1 mature chain was expressed in E. coli. |
Human Eotaxin-1 (CCL11 ) |
|
90127-B |
BPS Bioscience |
20 µg |
EUR 205 |
|
Description: Recombinant Eotaxin-1 is a disulfide-linked homodimeric protein consisting of 75 amino acid residues, and migrates as an approximately 9 kDa protein under non-reducing and reducing conditions in SDS-PAGE. Optimized DNA sequence encoding human Eotaxin-1 mature chain was expressed in E. coli. |
Human Eotaxin 3 (EOTAXIN-3) ELISA Kit |
|
MBS9359444-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human Eotaxin 3 (EOTAXIN-3) ELISA Kit |
|
MBS9359444-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Human Eotaxin 3 (EOTAXIN-3) ELISA Kit |
|
MBS9359444-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Human Eotaxin 3 (EOTAXIN-3) ELISA Kit |
|
MBS9359444-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Eotaxin-2 Human Recombinant (CCL24) (Eotaxin 2 Human) |
|
PT_40107 |
Novatein Biosciences, Inc. |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
Eotaxin-3 Human Recombinant (CCL26) (Eotaxin 3 Human) |
|
PT_40497 |
Novatein Biosciences, Inc. |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
Human Eotaxin-3 Antibody |
|
32586-05111 |
AssayPro |
150 ug |
EUR 215 |
anti- Eotaxin antibody |
|
FNab02791 |
FN Test |
100µg |
EUR 606.3 |
|
|
|
Description: Antibody raised against Eotaxin |
Eotaxin Human Recombinant (CCL11), His Tag (Eotaxin Human, His) |
|
PT_74237 |
Novatein Biosciences, Inc. |
-
Ask for price
-
Ask for price
-
Ask for price
|
|
Human Eotaxin-1 Antibody (Biotin Conjugate) |
|
34032-05121 |
AssayPro |
150 µg |
Ask for price |
Human Eotaxin 1 ELISA Kit |
|
201-12-0113 |
Shanghai Sunred Biological Technology |
96 tests |
EUR 528 |
|
|
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Human Eotaxin 1 ELISA kit |
|
E01A4313 |
BlueGene |
96T |
EUR 700 |
|
Description: ELISA |
Human Eotaxin 1 ELISA Kit |
|
MBS041649-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human Eotaxin 1 ELISA Kit |
|
MBS041649-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Human Eotaxin 1 ELISA Kit |
|
MBS041649-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Human Eotaxin 1 ELISA Kit |
|
MBS041649-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Human Eotaxin 1 ELISA kit |
|
E01E0364-192T |
BlueGene |
192 tests |
EUR 1524 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Human Eotaxin 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Eotaxin 1 ELISA kit |
|
E01E0364-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Human Eotaxin 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Eotaxin 1 ELISA kit |
|
E01E0364-48wellsplate |
BlueGene |
48 wells plate |
EUR 280 |
Human Eotaxin 1 ELISA kit |
|
E01E0364-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
|
|
Description: A competitive ELISA for quantitative measurement of Human Eotaxin 1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Eotaxin 1 ELISA kit |
|
E01E0364-96wellsplate |
BlueGene |
96 wells plate |
EUR 405 |
Human Eotaxin 1 ELISA Kit |
|
EHE0171 |
Abclonal |
96Tests |
EUR 625.2 |
Human Eotaxin 1 ELISA Kit |
|
EHE0371 |
Abclonal |
96Tests |
EUR 625.2 |
Human Eotaxin 1 ELISA Kit |
|
MBS3801283-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human Eotaxin 1 ELISA Kit |
|
MBS3801283-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Human Eotaxin 1 ELISA Kit |
|
MBS3801283-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Human Eotaxin 1 ELISA Kit |
|
MBS3801283-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Human Eotaxin 1 ELISA Kit |
|
MBS746305-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 5685 |
Human Eotaxin 1 ELISA Kit |
|
MBS746305-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 485 |
Human Eotaxin 1 ELISA Kit |
|
MBS746305-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3020 |
Human Eotaxin 1 ELISA Kit |
|
MBS746305-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 690 |
Human Eotaxin 1 ELISA Kit |
|
MBS9310422-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Human Eotaxin 1 ELISA Kit |
|
MBS728700-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 5685 |
Human Eotaxin 1 ELISA Kit |
|
MBS728700-48StripWells |
MyBiosource |
48-Strip-Wells |
EUR 485 |
Human Eotaxin 1 ELISA Kit |
|
MBS728700-5x96StripWells |
MyBiosource |
5x96-Strip-Wells |
EUR 3020 |
Human Eotaxin 1 ELISA Kit |
|
MBS728700-96StripWells |
MyBiosource |
96-Strip-Wells |
EUR 690 |
Human Eotaxin 1 ELISA Kit |
|
SL0662Hu |
Sunlong |
96 Tests |
EUR 468 |
|
|
Human Eotaxin 1 ELISA Kit |
|
CN-03168H1 |
ChemNorm |
96T |
EUR 592.8 |
Human Eotaxin 1 ELISA Kit |
|
CN-03168H2 |
ChemNorm |
48T |
EUR 412.8 |
Goat Anti-Human Eotaxin Antibody |
|
MBS5311076-005mg |
MyBiosource |
0.05mg |
EUR 465 |
Goat Anti-Human Eotaxin Antibody |
|
MBS5311076-5x005mg |
MyBiosource |
5x0.05mg |
EUR 1945 |
Anti-Human Eotaxin-2 Antibody |
|
101-M01 |
ReliaTech |
500 µg |
EUR 246.75 |
|
Description: Eotaxin2, also named MPIF-2 and Ckβ6, is a CC chemokine that is designated CCL24. Eotaxin2 cDNA encodes a 10.5 kDa, 119 amino acid residue precursor protein with a 26 aa residue signal peptide that is cleaved to generate a mature protein predicted to contain 93 amino acid residues with an N-glycosylation site. C-terminally truncated variants with 78, 73, 75 and 76 residues have also been described. Eotaxin 2 shares 40%, 42% and 39% amino acid sequence identity with other CC chemokines CCL7/MCP3, CCL3/MIP1α, and CCL11/Eotaxin, respectively. Eotaxin2 mRNA is weakly expressed in activated monocytes and T lymphocytes. Recombinant Eotaxin2 induces chemotaxis of eosinophils, basophils, and resting T lymphocytes, but not monocytes or activated T lymphocytes. Eotaxin2 also suppresses colony formation by high proliferative multipotential hematopoietic progenitors. On eosinophils, the effects of Eotaxin2, Eotaxin and CCL13/MCP4 are mediated by the receptor CCR3. |
Anti-Human Eotaxin-3 Antibody |
|
101-M19 |
ReliaTech |
500 µg |
EUR 246.75 |
|
Description: Eotaxin3, also named CCL26 or SCYA26, is a novel human CC chemokine that maps to chromosome 7q11.2, within 40 kilobases of the Eotaxin2 loci. Eotaxin3/ CCL26 has been shown to be constitutively expressed in the heart and ovary. In addition, low levels of Eotaxin3/ CCL26 expression can also be detected in various tissues. The expression of Eotaxin 3/CCL26 in vascular endothelial cells has been shown to be upregulated by IL13 and IL4. Eotaxin3/ CCL26 cDNA encodes a 94 amino acid (aa) residue protein with a putative signal peptide of either 23 or 26 aa residues. Eotaxin3/ CCL26 induces calcium flux in eosinophils as well as in CCR3transfected cells. Eotaxin 3/ CCL26 has also been shown to cross-desensitize cells to other CCR3 ligands. |
Anti-Human Eotaxin-2 Antibody |
|
102-P09G |
ReliaTech |
100 µg |
EUR 245.7 |
|
Description: Eotaxin2, also named MPIF-2 and Ckβ6, is a CC chemokine that is designated CCL24. Eotaxin2 cDNA encodes a 10.5 kDa, 119 amino acid residue precursor protein with a 26 aa residue signal peptide that is cleaved to generate a mature protein predicted to contain 93 amino acid residues with an N-glycosylation site. C-terminally truncated variants with 78, 73, 75 and 76 residues have also been described. Eotaxin 2 shares 40%, 42% and 39% amino acid sequence identity with other CC chemokines CCL7/MCP3, CCL3/MIP1α, and CCL11/Eotaxin, respectively. Eotaxin2 mRNA is weakly expressed in activated monocytes and T lymphocytes. Recombinant Eotaxin2 induces chemotaxis of eosinophils, basophils, and resting T lymphocytes, but not monocytes or activated T lymphocytes. Eotaxin2 also suppresses colony formation by high proliferative multipotential hematopoietic progenitors. On eosinophils, the effects of Eotaxin2, Eotaxin and CCL13/MCP4 are mediated by the receptor CCR3. |
Anti-Human Eotaxin-3 Antibody |
|
102-P10G |
ReliaTech |
100 µg |
EUR 245.7 |
|
Description: Eotaxin3, also named CCL26 or SCYA26, is a novel human CC chemokine that maps to chromosome 7q11.2, within 40 kilobases of the Eotaxin2 loci. Eotaxin3/ CCL26 has been shown to be constitutively expressed in the heart and ovary. In addition, low levels of Eotaxin3/ CCL26 expression can also be detected in various tissues. The expression of Eotaxin 3/CCL26 in vascular endothelial cells has been shown to be upregulated by IL13 and IL4. Eotaxin3/ CCL26 cDNA encodes a 94 amino acid (aa) residue protein with a putative signal peptide of either 23 or 26 aa residues. Eotaxin3/ CCL26 induces calcium flux in eosinophils as well as in CCR3transfected cells. Eotaxin 3/ CCL26 has also been shown to cross-desensitize cells to other CCR3 ligands. |
Anti-Human CCL11/Eotaxin Antibody |
|
MBS1569889-01mg |
MyBiosource |
0.1mg |
EUR 375 |
Anti-Human CCL11/Eotaxin Antibody |
|
MBS1569889-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1390 |
Plant Eotaxin 1 (EOTAXIN-1) ELISA Kit |
|
MBS9379715-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Anti-Human Eotaxin-2 (CCL24) |
|
MBS550663-01mg |
MyBiosource |
0.1mg |
EUR 260 |
Anti-Human Eotaxin-2 (CCL24) |
|
MBS550663-02mg |
MyBiosource |
0.2mg |
EUR 335 |
Anti-Human Eotaxin-3 (CCL26) |
|
MBS550664-01mg |
MyBiosource |
0.1mg |
EUR 260 |
Anti-Human Eotaxin-3 (CCL26) |
|
MBS550664-02mg |
MyBiosource |
0.2mg |
EUR 335 |
Anti-Human Eotaxin-3 (CCL26) |
|
MBS550676-01mg |
MyBiosource |
0.1mg |
EUR 260 |
Anti-Human Eotaxin-3 (CCL26) |
|
MBS550676-02mg |
MyBiosource |
0.2mg |
EUR 335 |
Mouse Anti-Human Eotaxin-2 |
|
MBS690296-05mg |
MyBiosource |
0.5mg |
EUR 525 |
Mouse Anti-Human Eotaxin-2 |
|
MBS690296-5x05mg |
MyBiosource |
5x0.5mg |
EUR 2080 |
Mouse Anti-Human Eotaxin-3 |
|
MBS690820-05mg |
MyBiosource |
0.5mg |
EUR 525 |
Mouse Anti-Human Eotaxin-3 |
|
MBS690820-5x05mg |
MyBiosource |
5x0.5mg |
EUR 2080 |
Eotaxin 1 antibody |
|
MBS834466-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
RABBIT ANTI PIG EOTAXIN 1 |
|
MBS225892-01mg |
MyBiosource |
0.1mg |
EUR 645 |
RABBIT ANTI PIG EOTAXIN 1 |
|
MBS225892-5x01mg |
MyBiosource |
5x0.1mg |
EUR 2730 |
Human Eotaxin (CCL11) |
|
1-CSB-EP004775HU |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10ug
- 50ug
- 100ug
- 200ug
- 500ug
- 1MG
|
|
|
|
Description: Recombinant Human Eotaxin(CCL11) expressed in E.coli |
Eotaxin, CCL11, human |
|
RC315-22 |
Bio Basic |
5ug |
EUR 125.26 |
|
|
Human Eotaxin-2 (CCL24) |
|
90128-A |
BPS Bioscience |
5 µg |
EUR 130 |
|
Description: Recombinant Eotaxin-2 is a disulfide-linked homodimeric protein consisting of 79 amino acid residues, and migrates as an approximately 9 kDa protein under non-reducing and reducing conditions in SDS-PAGE. Optimized DNA sequence encoding human Eotaxin-2 mature chain was expressed in E. coli. |
Human Eotaxin-2 (CCL24) |
|
90128-B |
BPS Bioscience |
20 µg |
EUR 205 |
|
Description: Recombinant Eotaxin-2 is a disulfide-linked homodimeric protein consisting of 79 amino acid residues, and migrates as an approximately 9 kDa protein under non-reducing and reducing conditions in SDS-PAGE. Optimized DNA sequence encoding human Eotaxin-2 mature chain was expressed in E. coli. |
Human Eotaxin-3(CCL26) |
|
90129-A |
BPS Bioscience |
5 µg |
EUR 130 |
|
Description: Recombinant Eotaxin-3 is a disulfide-linked homodimeric protein consisting of 72 amino acid residues, and migrates as an approximately 9 kDa protein under non-reducing and reducing conditions in SDS-PAGE. Optimized DNA sequence encoding human Eotaxin-3 mature chain was expressed in E. coli. |
Human Eotaxin-3(CCL26) |
|
90129-B |
BPS Bioscience |
20 µg |
EUR 205 |
|
Description: Recombinant Eotaxin-3 is a disulfide-linked homodimeric protein consisting of 72 amino acid residues, and migrates as an approximately 9 kDa protein under non-reducing and reducing conditions in SDS-PAGE. Optimized DNA sequence encoding human Eotaxin-3 mature chain was expressed in E. coli. |
Human Eotaxin-2 (CCL24) |
|
MBS691732-0005mg |
MyBiosource |
0.005mg |
EUR 300 |
Human Eotaxin-2 (CCL24) |
|
MBS691732-002mg |
MyBiosource |
0.02mg |
EUR 450 |
Human Eotaxin-2 (CCL24) |
|
MBS691732-5x002mg |
MyBiosource |
5x0.02mg |
EUR 1725 |
Human Eotaxin-3 (CCL26) |
|
MBS691877-0005mg |
MyBiosource |
0.005mg |
EUR 300 |
Human Eotaxin-3 (CCL26) |
|
MBS691877-002mg |
MyBiosource |
0.02mg |
EUR 450 |
Human Eotaxin-3 (CCL26) |
|
MBS691877-5x002mg |
MyBiosource |
5x0.02mg |
EUR 1725 |
Eotaxin-2, CCL24, human |
|
RC315-35 |
Bio Basic |
5ug |
EUR 125.26 |
|
|
Eotaxin-3, CCL26, human |
|
RC315-37 |
Bio Basic |
5ug |
EUR 121.6 |
|
|
Biotinylated Anti-Human Eotaxin |
|
GWB-BIG445 |
GenWay Biotech |
1 kit |
Ask for price |
Biotinylated Anti-Human Eotaxin |
|
GWB-BIG449 |
GenWay Biotech |
1 kit |
Ask for price |
Eotaxin-3, Human -BIOTIN |
|
GWB-700810 |
GenWay Biotech |
0.05 mg |
Ask for price |
KEY POINTS: • Catalytically energetic inclusion our bodies (CatIBs) are promising bionanomaterials. • Potential functions in biocatalysis, artificial chemistry, and biotechnology. • CatIB formation represents a generic strategy for enzyme immobilization. • CatIB formation effectivity relies on assemble design and expression circumstances.